Patients should undergo baseline assessment including HbA1c and renal function
Semaglutide and GLP-1MK-801, but not MK-801 monotherapy, lowered food intake in rats, with GLP-1MK-801 treatment resulting in a more pronounced reduction compared with semaglutide (Fig
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes mellitus and, more recently, for weight management in specific patient populations
Individuals with type 2 diabetes typically experience an impaired incretin effect, though GLP-1 secretion itself may be normal, slightly reduced, or context-dependent
Timing of Dosing : Some individuals find that taking their GLP-1 medication at a specific time of day, such as in the evening, helps them sleep through some of the initial side effects
GLP-1 medications (like Ozempic and Wegovy) manage Type 2 diabetes and obesity